Literature DB >> 18304177

Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.

Ashley R Mason1, Gil Y Cortes, Ross B Pollack.   

Abstract

Nevirapine is a non-nucleoside reverse transcriptase inhibitor commonly used in human immunodeficiency virus-1 multidrug regimens and associated with life-threatening cutaneous reactions. Here, we report the successful use of intravenous immunoglobulin in a pediatric patient with Stevens-Johnson syndrome and highlight the risk of nevirapine usage in human immunodeficiency virus postexposure prophylaxis.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18304177     DOI： 10.1111/j.1525-1470.2007.00605.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  3 in total

1.  Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review.

Authors:  Krystyna Romańska-Gocka; Jacek Gocki; Waldemar Placek; Barbara Zegarska; Paweł Krause
Journal:  Arch Med Sci       Date:  2010-03-09       Impact factor: 3.318

2.  A study on oral mucosal lesions in 3500 patients with dermatological diseases in South India.

Authors:  Rs Arvind Babu; P Chandrashekar; K Kiran Kumar; G Sridhar Reddy; K Lalith Prakash Chandra; V Rao; Bvr Reddy
Journal:  Ann Med Health Sci Res       Date:  2014-07

3.  Nevirapine-induced Stevens-Johnson syndrome in children living with HIV in South Africa.

Authors:  Jacques D du Toit; Koot Kotze; Helene-Mari van der Westhuizen; Taryn L Gaunt
Journal:  South Afr J HIV Med       Date:  2021-02-23       Impact factor: 2.744
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.